Fusion sequencing via terminator‐assisted synthesis (FTAS ‐seq) identifies TMPRSS2 fusion partners in prostate cancer
Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1002/1878-0261.13428
Genetic rearrangements that fuse an androgen‐regulated promoter area with a protein‐coding portion of an originally androgen‐unaffected gene are frequent in prostate cancer, with the fusion between transmembrane serine protease 2 ( TMPRSS2 ) and ETS transcription factor ERG ( ERG ) ( TMPRSS2‐ERG fusion) being the most prevalent. Conventional hybridization‐ or amplification‐based methods can test for the presence of expected gene fusions, but the exploratory analysis of currently unknown fusion partners is often cost‐prohibitive. Here, we developed an innovative next‐generation sequencing (NGS)‐based approach for gene fusion analysis termed fusion sequencing via terminator‐assisted synthesis (FTAS‐seq). FTAS‐seq can be used to enrich the gene of interest while simultaneously profiling the whole spectrum of its 3′‐terminal fusion partners. Using this novel semi‐targeted RNA‐sequencing technique, we were able to identify 11 previously uncharacterized TMPRSS2 fusion partners and capture a range of TMPRSS2‐ERG isoforms. We tested the performance of FTAS‐seq with well‐characterized prostate cancer cell lines and utilized the technique for the analysis of patient RNA samples. FTAS‐seq chemistry combined with appropriate primer panels holds great potential as a tool for biomarker discovery that can support the development of personalized cancer therapies.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/1878-0261.13428
- OA Status
- gold
- Cited By
- 3
- References
- 57
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362555387
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362555387Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/1878-0261.13428Digital Object Identifier
- Title
-
Fusion sequencing via terminator‐assisted synthesis (
FTAS ‐seq) identifies TMPRSS2 fusion partners in prostate cancerWork title - Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-04Full publication date if available
- Authors
-
Ugnė Drazdauskienė, Žana Kapustina, Justina Medžiūnė, Varvara Dubovskaja, Rasa Sabaliauskaitė, Sonata Jarmalaitė, Arvydas LubysList of authors in order
- Landing page
-
https://doi.org/10.1002/1878-0261.13428Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1002/1878-0261.13428Direct OA link when available
- Concepts
-
Prostate cancer, TMPRSS2, Terminator (solar), Fusion gene, Computational biology, Cancer research, Fusion, Fusion protein, Biology, Cancer, Medicine, Genetics, Coronavirus disease 2019 (COVID-19), Internal medicine, Gene, Recombinant DNA, Ionosphere, Infectious disease (medical specialty), Astronomy, Physics, Philosophy, Disease, LinguisticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
57Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362555387 |
|---|---|
| doi | https://doi.org/10.1002/1878-0261.13428 |
| ids.doi | https://doi.org/10.1002/1878-0261.13428 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37300660 |
| ids.openalex | https://openalex.org/W4362555387 |
| fwci | 1.01212496 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D008297 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Male |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000728 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Androgens |
| mesh[3].qualifier_ui | Q000235 |
| mesh[3].descriptor_ui | D015514 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | genetics |
| mesh[3].descriptor_name | Oncogene Proteins, Fusion |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D015514 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | Oncogene Proteins, Fusion |
| mesh[5].qualifier_ui | Q000235 |
| mesh[5].descriptor_ui | D011471 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | genetics |
| mesh[5].descriptor_name | Prostatic Neoplasms |
| mesh[6].qualifier_ui | Q000378 |
| mesh[6].descriptor_ui | D011471 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | metabolism |
| mesh[6].descriptor_name | Prostatic Neoplasms |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D001483 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Base Sequence |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D012313 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | RNA |
| mesh[9].qualifier_ui | Q000235 |
| mesh[9].descriptor_ui | D012697 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | genetics |
| mesh[9].descriptor_name | Serine Endopeptidases |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D012697 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Serine Endopeptidases |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008297 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Male |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000728 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Androgens |
| mesh[14].qualifier_ui | Q000235 |
| mesh[14].descriptor_ui | D015514 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | genetics |
| mesh[14].descriptor_name | Oncogene Proteins, Fusion |
| mesh[15].qualifier_ui | Q000378 |
| mesh[15].descriptor_ui | D015514 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | metabolism |
| mesh[15].descriptor_name | Oncogene Proteins, Fusion |
| mesh[16].qualifier_ui | Q000235 |
| mesh[16].descriptor_ui | D011471 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | genetics |
| mesh[16].descriptor_name | Prostatic Neoplasms |
| mesh[17].qualifier_ui | Q000378 |
| mesh[17].descriptor_ui | D011471 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | metabolism |
| mesh[17].descriptor_name | Prostatic Neoplasms |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D001483 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Base Sequence |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D012313 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | RNA |
| mesh[20].qualifier_ui | Q000235 |
| mesh[20].descriptor_ui | D012697 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | genetics |
| mesh[20].descriptor_name | Serine Endopeptidases |
| mesh[21].qualifier_ui | Q000378 |
| mesh[21].descriptor_ui | D012697 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | metabolism |
| mesh[21].descriptor_name | Serine Endopeptidases |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008297 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Male |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000728 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Androgens |
| mesh[25].qualifier_ui | Q000235 |
| mesh[25].descriptor_ui | D015514 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | genetics |
| mesh[25].descriptor_name | Oncogene Proteins, Fusion |
| mesh[26].qualifier_ui | Q000378 |
| mesh[26].descriptor_ui | D015514 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | metabolism |
| mesh[26].descriptor_name | Oncogene Proteins, Fusion |
| mesh[27].qualifier_ui | Q000235 |
| mesh[27].descriptor_ui | D011471 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | genetics |
| mesh[27].descriptor_name | Prostatic Neoplasms |
| mesh[28].qualifier_ui | Q000378 |
| mesh[28].descriptor_ui | D011471 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | metabolism |
| mesh[28].descriptor_name | Prostatic Neoplasms |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D001483 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Base Sequence |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D012313 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | RNA |
| mesh[31].qualifier_ui | Q000235 |
| mesh[31].descriptor_ui | D012697 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | genetics |
| mesh[31].descriptor_name | Serine Endopeptidases |
| mesh[32].qualifier_ui | Q000378 |
| mesh[32].descriptor_ui | D012697 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | metabolism |
| mesh[32].descriptor_name | Serine Endopeptidases |
| type | article |
| title | Fusion sequencing via terminator‐assisted synthesis ( |
| biblio.issue | 6 |
| biblio.volume | 17 |
| biblio.last_page | 1006 |
| biblio.first_page | 993 |
| topics[0].id | https://openalex.org/T10543 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Prostate Cancer Treatment and Research |
| topics[1].id | https://openalex.org/T11482 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9973999857902527 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | RNA modifications and cancer |
| topics[2].id | https://openalex.org/T11395 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9955999851226807 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Radiopharmaceutical Chemistry and Applications |
| is_xpac | False |
| apc_list.value | 3600 |
| apc_list.currency | USD |
| apc_list.value_usd | 3600 |
| apc_paid.value | 3600 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3600 |
| concepts[0].id | https://openalex.org/C2780192828 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7852985858917236 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q181257 |
| concepts[0].display_name | Prostate cancer |
| concepts[1].id | https://openalex.org/C2778042024 |
| concepts[1].level | 5 |
| concepts[1].score | 0.7227562069892883 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q18032025 |
| concepts[1].display_name | TMPRSS2 |
| concepts[2].id | https://openalex.org/C178046730 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5276925563812256 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q331824 |
| concepts[2].display_name | Terminator (solar) |
| concepts[3].id | https://openalex.org/C111829193 |
| concepts[3].level | 3 |
| concepts[3].score | 0.4660303294658661 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1108970 |
| concepts[3].display_name | Fusion gene |
| concepts[4].id | https://openalex.org/C70721500 |
| concepts[4].level | 1 |
| concepts[4].score | 0.46090707182884216 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[4].display_name | Computational biology |
| concepts[5].id | https://openalex.org/C502942594 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4601576328277588 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[5].display_name | Cancer research |
| concepts[6].id | https://openalex.org/C158525013 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4420330822467804 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2593739 |
| concepts[6].display_name | Fusion |
| concepts[7].id | https://openalex.org/C123894998 |
| concepts[7].level | 4 |
| concepts[7].score | 0.41103535890579224 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q425158 |
| concepts[7].display_name | Fusion protein |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.4014222025871277 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.29621031880378723 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| concepts[10].id | https://openalex.org/C71924100 |
| concepts[10].level | 0 |
| concepts[10].score | 0.26624324917793274 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[10].display_name | Medicine |
| concepts[11].id | https://openalex.org/C54355233 |
| concepts[11].level | 1 |
| concepts[11].score | 0.22039535641670227 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[11].display_name | Genetics |
| concepts[12].id | https://openalex.org/C3008058167 |
| concepts[12].level | 4 |
| concepts[12].score | 0.21072223782539368 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[12].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[13].id | https://openalex.org/C126322002 |
| concepts[13].level | 1 |
| concepts[13].score | 0.17566952109336853 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[13].display_name | Internal medicine |
| concepts[14].id | https://openalex.org/C104317684 |
| concepts[14].level | 2 |
| concepts[14].score | 0.1630796194076538 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[14].display_name | Gene |
| concepts[15].id | https://openalex.org/C40767141 |
| concepts[15].level | 3 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q285697 |
| concepts[15].display_name | Recombinant DNA |
| concepts[16].id | https://openalex.org/C116403925 |
| concepts[16].level | 2 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q162219 |
| concepts[16].display_name | Ionosphere |
| concepts[17].id | https://openalex.org/C524204448 |
| concepts[17].level | 3 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[17].display_name | Infectious disease (medical specialty) |
| concepts[18].id | https://openalex.org/C1276947 |
| concepts[18].level | 1 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q333 |
| concepts[18].display_name | Astronomy |
| concepts[19].id | https://openalex.org/C121332964 |
| concepts[19].level | 0 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[19].display_name | Physics |
| concepts[20].id | https://openalex.org/C138885662 |
| concepts[20].level | 0 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[20].display_name | Philosophy |
| concepts[21].id | https://openalex.org/C2779134260 |
| concepts[21].level | 2 |
| concepts[21].score | 0.0 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[21].display_name | Disease |
| concepts[22].id | https://openalex.org/C41895202 |
| concepts[22].level | 1 |
| concepts[22].score | 0.0 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q8162 |
| concepts[22].display_name | Linguistics |
| keywords[0].id | https://openalex.org/keywords/prostate-cancer |
| keywords[0].score | 0.7852985858917236 |
| keywords[0].display_name | Prostate cancer |
| keywords[1].id | https://openalex.org/keywords/tmprss2 |
| keywords[1].score | 0.7227562069892883 |
| keywords[1].display_name | TMPRSS2 |
| keywords[2].id | https://openalex.org/keywords/terminator |
| keywords[2].score | 0.5276925563812256 |
| keywords[2].display_name | Terminator (solar) |
| keywords[3].id | https://openalex.org/keywords/fusion-gene |
| keywords[3].score | 0.4660303294658661 |
| keywords[3].display_name | Fusion gene |
| keywords[4].id | https://openalex.org/keywords/computational-biology |
| keywords[4].score | 0.46090707182884216 |
| keywords[4].display_name | Computational biology |
| keywords[5].id | https://openalex.org/keywords/cancer-research |
| keywords[5].score | 0.4601576328277588 |
| keywords[5].display_name | Cancer research |
| keywords[6].id | https://openalex.org/keywords/fusion |
| keywords[6].score | 0.4420330822467804 |
| keywords[6].display_name | Fusion |
| keywords[7].id | https://openalex.org/keywords/fusion-protein |
| keywords[7].score | 0.41103535890579224 |
| keywords[7].display_name | Fusion protein |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.4014222025871277 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.29621031880378723 |
| keywords[9].display_name | Cancer |
| keywords[10].id | https://openalex.org/keywords/medicine |
| keywords[10].score | 0.26624324917793274 |
| keywords[10].display_name | Medicine |
| keywords[11].id | https://openalex.org/keywords/genetics |
| keywords[11].score | 0.22039535641670227 |
| keywords[11].display_name | Genetics |
| keywords[12].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[12].score | 0.21072223782539368 |
| keywords[12].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[13].id | https://openalex.org/keywords/internal-medicine |
| keywords[13].score | 0.17566952109336853 |
| keywords[13].display_name | Internal medicine |
| keywords[14].id | https://openalex.org/keywords/gene |
| keywords[14].score | 0.1630796194076538 |
| keywords[14].display_name | Gene |
| language | en |
| locations[0].id | doi:10.1002/1878-0261.13428 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S80282989 |
| locations[0].source.issn | 1574-7891, 1878-0261 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1574-7891 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Molecular Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Molecular Oncology |
| locations[0].landing_page_url | https://doi.org/10.1002/1878-0261.13428 |
| locations[1].id | pmid:37300660 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Molecular oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37300660 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10257418 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10257418/pdf/MOL2-17-993.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Mol Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10257418 |
| locations[3].id | pmh:oai:doaj.org/article:cc538dc391284a1c92c5dc1a34c88299 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Molecular Oncology, Vol 17, Iss 6, Pp 993-1006 (2023) |
| locations[3].landing_page_url | https://doaj.org/article/cc538dc391284a1c92c5dc1a34c88299 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5023087069 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ugnė Drazdauskienė |
| authorships[0].countries | LT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210128137 |
| authorships[0].affiliations[0].raw_affiliation_string | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[0].institutions[0].id | https://openalex.org/I4210128137 |
| authorships[0].institutions[0].ror | https://ror.org/030anrr19 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210128137, https://openalex.org/I4210142480 |
| authorships[0].institutions[0].country_code | LT |
| authorships[0].institutions[0].display_name | Thermo Fisher Scientific (Lithuania) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ugnė Drazdauskienė |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[1].author.id | https://openalex.org/A5000878728 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1482-9536 |
| authorships[1].author.display_name | Žana Kapustina |
| authorships[1].countries | LT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210128137 |
| authorships[1].affiliations[0].raw_affiliation_string | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[1].institutions[0].id | https://openalex.org/I4210128137 |
| authorships[1].institutions[0].ror | https://ror.org/030anrr19 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210128137, https://openalex.org/I4210142480 |
| authorships[1].institutions[0].country_code | LT |
| authorships[1].institutions[0].display_name | Thermo Fisher Scientific (Lithuania) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Žana Kapustina |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[2].author.id | https://openalex.org/A5078613483 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0474-5184 |
| authorships[2].author.display_name | Justina Medžiūnė |
| authorships[2].countries | LT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210128137 |
| authorships[2].affiliations[0].raw_affiliation_string | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[2].institutions[0].id | https://openalex.org/I4210128137 |
| authorships[2].institutions[0].ror | https://ror.org/030anrr19 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210128137, https://openalex.org/I4210142480 |
| authorships[2].institutions[0].country_code | LT |
| authorships[2].institutions[0].display_name | Thermo Fisher Scientific (Lithuania) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Justina Medžiūnė |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[3].author.id | https://openalex.org/A5079112378 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Varvara Dubovskaja |
| authorships[3].countries | LT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210128137 |
| authorships[3].affiliations[0].raw_affiliation_string | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[3].institutions[0].id | https://openalex.org/I4210128137 |
| authorships[3].institutions[0].ror | https://ror.org/030anrr19 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210128137, https://openalex.org/I4210142480 |
| authorships[3].institutions[0].country_code | LT |
| authorships[3].institutions[0].display_name | Thermo Fisher Scientific (Lithuania) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Varvara Dubovskaja |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[4].author.id | https://openalex.org/A5007431308 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3465-3558 |
| authorships[4].author.display_name | Rasa Sabaliauskaitė |
| authorships[4].countries | LT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210153145 |
| authorships[4].affiliations[0].raw_affiliation_string | National Cancer Institute, Vilnius, Lithuania |
| authorships[4].institutions[0].id | https://openalex.org/I4210153145 |
| authorships[4].institutions[0].ror | https://ror.org/04w2jh416 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210153145 |
| authorships[4].institutions[0].country_code | LT |
| authorships[4].institutions[0].display_name | National Cancer Institute |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Rasa Sabaliauskaitė |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | National Cancer Institute, Vilnius, Lithuania |
| authorships[5].author.id | https://openalex.org/A5085485237 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3719-0891 |
| authorships[5].author.display_name | Sonata Jarmalaitė |
| authorships[5].countries | LT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I173212132 |
| authorships[5].affiliations[0].raw_affiliation_string | Institute of Biosciences, Life Sciences Center, Vilnius University, Lithuania |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210153145 |
| authorships[5].affiliations[1].raw_affiliation_string | National Cancer Institute, Vilnius, Lithuania |
| authorships[5].institutions[0].id | https://openalex.org/I4210153145 |
| authorships[5].institutions[0].ror | https://ror.org/04w2jh416 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210153145 |
| authorships[5].institutions[0].country_code | LT |
| authorships[5].institutions[0].display_name | National Cancer Institute |
| authorships[5].institutions[1].id | https://openalex.org/I173212132 |
| authorships[5].institutions[1].ror | https://ror.org/03nadee84 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I173212132 |
| authorships[5].institutions[1].country_code | LT |
| authorships[5].institutions[1].display_name | Vilnius University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sonata Jarmalaitė |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Institute of Biosciences, Life Sciences Center, Vilnius University, Lithuania, National Cancer Institute, Vilnius, Lithuania |
| authorships[6].author.id | https://openalex.org/A5073734787 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5050-503X |
| authorships[6].author.display_name | Arvydas Lubys |
| authorships[6].countries | LT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210128137 |
| authorships[6].affiliations[0].raw_affiliation_string | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| authorships[6].institutions[0].id | https://openalex.org/I4210128137 |
| authorships[6].institutions[0].ror | https://ror.org/030anrr19 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210128137, https://openalex.org/I4210142480 |
| authorships[6].institutions[0].country_code | LT |
| authorships[6].institutions[0].display_name | Thermo Fisher Scientific (Lithuania) |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Arvydas Lubys |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Thermo Fisher Scientific Baltics, Vilnius, Lithuania |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1002/1878-0261.13428 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2023-04-06T00:00:00 |
| display_name | Fusion sequencing via terminator‐assisted synthesis ( |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10543 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Prostate Cancer Treatment and Research |
| related_works | https://openalex.org/W1579271360, https://openalex.org/W2391393445, https://openalex.org/W2137934906, https://openalex.org/W2089087147, https://openalex.org/W2050815876, https://openalex.org/W3029360577, https://openalex.org/W2053705592, https://openalex.org/W2351758388, https://openalex.org/W2092605924, https://openalex.org/W1981550937 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1002/1878-0261.13428 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S80282989 |
| best_oa_location.source.issn | 1574-7891, 1878-0261 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1574-7891 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Molecular Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Molecular Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/1878-0261.13428 |
| primary_location.id | doi:10.1002/1878-0261.13428 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S80282989 |
| primary_location.source.issn | 1574-7891, 1878-0261 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1574-7891 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Molecular Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Molecular Oncology |
| primary_location.landing_page_url | https://doi.org/10.1002/1878-0261.13428 |
| publication_date | 2023-04-04 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2107633226, https://openalex.org/W3126759399, https://openalex.org/W2121158863, https://openalex.org/W2161112598, https://openalex.org/W4310193548, https://openalex.org/W1992079095, https://openalex.org/W2566313243, https://openalex.org/W1790423369, https://openalex.org/W2063370830, https://openalex.org/W2027963144, https://openalex.org/W2272111630, https://openalex.org/W2136452881, https://openalex.org/W2016538215, https://openalex.org/W2093313503, https://openalex.org/W3017149347, https://openalex.org/W1810761522, https://openalex.org/W2051110031, https://openalex.org/W2923956523, https://openalex.org/W2062291041, https://openalex.org/W4255738661, https://openalex.org/W2169456326, https://openalex.org/W2137586531, https://openalex.org/W2120076861, https://openalex.org/W2107208863, https://openalex.org/W3118238647, https://openalex.org/W1490196907, https://openalex.org/W4220907202, https://openalex.org/W1982956208, https://openalex.org/W2796292093, https://openalex.org/W3162941452, https://openalex.org/W6800301266, https://openalex.org/W2807773783, https://openalex.org/W3004498009, https://openalex.org/W3136190116, https://openalex.org/W2915524647, https://openalex.org/W3177170937, https://openalex.org/W1967548067, https://openalex.org/W2050235247, https://openalex.org/W3128858085, https://openalex.org/W4242189890, https://openalex.org/W2981311269, https://openalex.org/W2095202886, https://openalex.org/W4306879831, https://openalex.org/W2802806937, https://openalex.org/W2038714085, https://openalex.org/W2139531858, https://openalex.org/W2089202189, https://openalex.org/W3157633389, https://openalex.org/W3208463219, https://openalex.org/W2108058966, https://openalex.org/W2132341951, https://openalex.org/W4317034776, https://openalex.org/W3133505535, https://openalex.org/W2065799563, https://openalex.org/W2169428763, https://openalex.org/W2110417468, https://openalex.org/W3196570134 |
| referenced_works_count | 57 |
| abstract_inverted_index.( | 30, 38, 41 |
| abstract_inverted_index.) | 32, 40 |
| abstract_inverted_index.2 | 29 |
| abstract_inverted_index.a | 9, 134, 173 |
| abstract_inverted_index.11 | 126 |
| abstract_inverted_index.We | 139 |
| abstract_inverted_index.an | 4, 13, 77 |
| abstract_inverted_index.as | 172 |
| abstract_inverted_index.be | 96 |
| abstract_inverted_index.in | 19 |
| abstract_inverted_index.is | 71 |
| abstract_inverted_index.of | 12, 58, 66, 102, 110, 136, 143, 158, 183 |
| abstract_inverted_index.or | 50 |
| abstract_inverted_index.to | 98, 124 |
| abstract_inverted_index.we | 75, 121 |
| abstract_inverted_index.ERG | 37, 39 |
| abstract_inverted_index.ETS | 34 |
| abstract_inverted_index.RNA | 160 |
| abstract_inverted_index.and | 33, 132, 151 |
| abstract_inverted_index.are | 17 |
| abstract_inverted_index.but | 62 |
| abstract_inverted_index.can | 53, 95, 179 |
| abstract_inverted_index.for | 55, 83, 155, 175 |
| abstract_inverted_index.its | 111 |
| abstract_inverted_index.the | 23, 45, 56, 63, 100, 107, 141, 153, 156, 181 |
| abstract_inverted_index.via | 90 |
| abstract_inverted_index.able | 123 |
| abstract_inverted_index.area | 7 |
| abstract_inverted_index.cell | 149 |
| abstract_inverted_index.fuse | 3 |
| abstract_inverted_index.gene | 16, 60, 84, 101 |
| abstract_inverted_index.most | 46 |
| abstract_inverted_index.test | 54 |
| abstract_inverted_index.that | 2, 178 |
| abstract_inverted_index.this | 116 |
| abstract_inverted_index.tool | 174 |
| abstract_inverted_index.used | 97 |
| abstract_inverted_index.were | 122 |
| abstract_inverted_index.with | 8, 22, 145, 165 |
| abstract_inverted_index.Here, | 74 |
| abstract_inverted_index.Using | 115 |
| abstract_inverted_index.being | 44 |
| abstract_inverted_index.great | 170 |
| abstract_inverted_index.holds | 169 |
| abstract_inverted_index.lines | 150 |
| abstract_inverted_index.novel | 117 |
| abstract_inverted_index.often | 72 |
| abstract_inverted_index.range | 135 |
| abstract_inverted_index.while | 104 |
| abstract_inverted_index.whole | 108 |
| abstract_inverted_index.cancer | 148, 185 |
| abstract_inverted_index.enrich | 99 |
| abstract_inverted_index.factor | 36 |
| abstract_inverted_index.fusion | 24, 69, 85, 88, 113, 130 |
| abstract_inverted_index.panels | 168 |
| abstract_inverted_index.primer | 167 |
| abstract_inverted_index.serine | 27 |
| abstract_inverted_index.termed | 87 |
| abstract_inverted_index.tested | 140 |
| abstract_inverted_index.Genetic | 0 |
| abstract_inverted_index.TMPRSS2 | 31, 129 |
| abstract_inverted_index.between | 25 |
| abstract_inverted_index.cancer, | 21 |
| abstract_inverted_index.capture | 133 |
| abstract_inverted_index.fusion) | 43 |
| abstract_inverted_index.methods | 52 |
| abstract_inverted_index.patient | 159 |
| abstract_inverted_index.portion | 11 |
| abstract_inverted_index.support | 180 |
| abstract_inverted_index.unknown | 68 |
| abstract_inverted_index.analysis | 65, 86, 157 |
| abstract_inverted_index.approach | 82 |
| abstract_inverted_index.combined | 164 |
| abstract_inverted_index.expected | 59 |
| abstract_inverted_index.frequent | 18 |
| abstract_inverted_index.fusions, | 61 |
| abstract_inverted_index.identify | 125 |
| abstract_inverted_index.interest | 103 |
| abstract_inverted_index.partners | 70, 131 |
| abstract_inverted_index.presence | 57 |
| abstract_inverted_index.promoter | 6 |
| abstract_inverted_index.prostate | 20, 147 |
| abstract_inverted_index.protease | 28 |
| abstract_inverted_index.samples. | 161 |
| abstract_inverted_index.spectrum | 109 |
| abstract_inverted_index.utilized | 152 |
| abstract_inverted_index.biomarker | 176 |
| abstract_inverted_index.chemistry | 163 |
| abstract_inverted_index.currently | 67 |
| abstract_inverted_index.developed | 76 |
| abstract_inverted_index.discovery | 177 |
| abstract_inverted_index.isoforms. | 138 |
| abstract_inverted_index.partners. | 114 |
| abstract_inverted_index.potential | 171 |
| abstract_inverted_index.profiling | 106 |
| abstract_inverted_index.synthesis | 92 |
| abstract_inverted_index.technique | 154 |
| abstract_inverted_index.FTAS‐seq | 94, 144, 162 |
| abstract_inverted_index.innovative | 78 |
| abstract_inverted_index.originally | 14 |
| abstract_inverted_index.prevalent. | 47 |
| abstract_inverted_index.previously | 127 |
| abstract_inverted_index.sequencing | 80, 89 |
| abstract_inverted_index.technique, | 120 |
| abstract_inverted_index.therapies. | 186 |
| abstract_inverted_index.appropriate | 166 |
| abstract_inverted_index.development | 182 |
| abstract_inverted_index.exploratory | 64 |
| abstract_inverted_index.performance | 142 |
| abstract_inverted_index.Conventional | 48 |
| abstract_inverted_index.personalized | 184 |
| abstract_inverted_index.(FTAS‐seq). | 93 |
| abstract_inverted_index.(NGS)‐based | 81 |
| abstract_inverted_index.TMPRSS2‐ERG | 42, 137 |
| abstract_inverted_index.transcription | 35 |
| abstract_inverted_index.transmembrane | 26 |
| abstract_inverted_index.rearrangements | 1 |
| abstract_inverted_index.simultaneously | 105 |
| abstract_inverted_index.3′‐terminal | 112 |
| abstract_inverted_index.semi‐targeted | 118 |
| abstract_inverted_index.uncharacterized | 128 |
| abstract_inverted_index.RNA‐sequencing | 119 |
| abstract_inverted_index.hybridization‐ | 49 |
| abstract_inverted_index.protein‐coding | 10 |
| abstract_inverted_index.next‐generation | 79 |
| abstract_inverted_index.cost‐prohibitive. | 73 |
| abstract_inverted_index.androgen‐regulated | 5 |
| abstract_inverted_index.well‐characterized | 146 |
| abstract_inverted_index.amplification‐based | 51 |
| abstract_inverted_index.androgen‐unaffected | 15 |
| abstract_inverted_index.terminator‐assisted | 91 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5000878728, https://openalex.org/A5073734787 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I4210128137 |
| citation_normalized_percentile.value | 0.76240527 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |